Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis

Allergy and Asthma Proceedings

Volumn 33, Issue 2, 2012, Pages

  Yamamoto, Hideyuki ^a   Yamada, Takechiyo ^a   Sakashita, Masafumi ^a   Kubo, Seita ^a   Susuki, Dai ^a   Tokunaga, Takahiro ^a   Ogi, Kazuhiro ^a   Terasawa, Yoko ^a   Yamashita, Shinji ^a   Kayano, Yuichiro ^a   Masada, Mikio ^a   Kimura, Yuichi ^a   Fujieda, Shigeharu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KETOTIFEN; LORATADINE; MOMETASONE FUROATE; MONTELUKAST; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EYE DISEASE; FEMALE; HAY FEVER; HUMAN; JAPANESE CEDAR; MAJOR CLINICAL STUDY; MALE; NASAL CONGESTION SCORE; NOSE CONGESTION; OCULAR SYMPTOM SCORE; POLLEN; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; RHINORRHEA SCORE; SCORING SYSTEM; SNEEZING; SNEEZING SCORE; TOTAL NASAL SYMPTOM SCORE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ACETATES; ADMINISTRATION, ORAL; ADULT; ANTI-ALLERGIC AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; LORATADINE; MALE; PLACEBOS; POLLEN; QUINOLINES; RHINITIS, ALLERGIC, SEASONAL; SNEEZING; TIME FACTORS;

EID: 84860243180     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2012.33.3514     Document Type: Article

References (20)

1. Montuschi P, Sala A, Dahlén SE, et al. Pharmacological modulation of the leukotriene pathway in allergic airway disease. Drug Discov Today 12:404-412, 2007. (Pubitemid 46636374)
2. Meliton AY, Munoz NM, and Leff AR. Blockade of avidity and focal clustering of beta 2-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion. J Allergy Clin Immunol 120:1316-1323, 2007. (Pubitemid 350225682)
3. Wilson AM, O'Byrne PM, and Parameswaran K. Leukotriene receptor antagonists for allergic rhinitis: A systematic review and meta-analysis. Am J Med 116:338-344, 2004. (Pubitemid 38230294)
4. Rodrigo GJ, and Yanez A. The role antileukotriene therapy in seasonal allergic rhinitis: A systematic review of randomized trials. Ann Allergy Asthma Immunol 96:779-786, 2006.
5. Lagos JA, and Marshall GD. Montelukast in the management of allergic rhinitis. Ther Clin Risk Manag 3:327-332, 2007. (Pubitemid 46881460)
6. Nayak A, and Langdon RB. Montelukast in the treatment of allergic rhinitis: An evidence-based review. Drugs 67:887-901, 2007. (Pubitemid 46607389)
7. Sakashita M, Hirota T, Harada M, et al. Prevalence of allergic rhinitis and sensitization to common aeroallergens in a Japanese population. Int Arch Allergy Immunol 151:255-261, 2009.
8. Okamoto Y, Horiguchi S, Yamamoto H, et al. Present situation of cedar pollinosis in Japan and its immune responses. Allergol Int 58:155-162, 2009.
9. Yamamoto H, Yamada T, Kubo S, et al. Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study. Allergy Asthma Proc 31:296-303, 2010.
10. Okubo K, Kurono Y, Fujieda S, et al. Japanese guideline for allergic rhinitis. Allergol Int 60:171-189, 2011.
11. Okubo K, and Baba K. Therapeutic effect of montelukast, a cysteinyl leukotriene receptor 1 antagonist, on Japanese patients with seasonal allergic rhinitis. Allergol Int 57:247-255, 2008.
12. Yonekura S, Okamoto Y, Okubo K, et al. Beneficial effects of leukotriene receptor antagonists in the prevention of cedar pollinosis in a community setting. J Investig Allergol Clin Immunol 19:195-203, 2009.
13. Ito K, Terada T, Yuki A, et al. Preliminary study of a challenge test to the patients with Japanese cedar pollinosis using an environmental exposure unit. Auris Nasus Larynx 37:694-699, 2010.
14. Okubo K, Uchida E, and Nogami S. Levocabastine nasal spray significantly improves perennial allergic rhinitis: A single-blind placebo-controlled study. Auris Nasus Larynx. 37:436-442, 2010.
15. Makino Y, Noguchi E, Takahashi N, et al. Apolipoprotein A-IV is a candidate target molecule for the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 126:1163-1169, 2010.
16. Plaut M, and Valentine MD. Clinical practice. Allergic rhinitis. N Engl J Med 353:1934-1944, 2005.
17. Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 105:917-922, 2000. (Pubitemid 30324400)
18. Nayak AS, Philip G, Lu S, et al. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol 88:592-600, 2002. (Pubitemid 36183813)
19. Prenner B, Anolik R, Danzig M, et al. Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: Effects on nasal congestion. Allergy Asthma Proc 30:263-269, 2009.
20. Prenner BM, Lu S, and Danzig MR. Safety of fixed-dose loratadine/montelukast in subjects with allergic rhinitis. Allergy Asthma Proc 31:493-498, 2010.